Assertio Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth Quarter Net Product Sales $32.5 Million, Cash Flow from Operations of$5.7 Million 2024 Full Year Outlook for Net Product Sales of $110 to$125 Million, Adjusted EBITDA of $20 to$30 Million LAKE FOREST, Il., March 11, 2024 (GLOBE NEWSWIRE) --  Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today reported financial results for the fourth quarter and full year ended D ...